News & Features

Be sure to check back frequently for updates. A complete list of news items can be found on our News page.

Clinical Development Path

pxradia is pursuing fast-track product approval for humanized monoclonal antibody 2A2 using "The Animal Rule" under which only human safety and pharmacokinetic studies are required.

learn more >

Antibody Therapy for Radiation Exposure

Humanized monoclonal antibody 2A2 is being developed as a radiation mitigator. It works by inhibiting cell apoptosis or "cell suicide" which results from a lethal dose of radiation.

learn more >